FLT4 antibody
Quick Overview for FLT4 antibody (ABIN2843906)
Target
See all FLT4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- This antibody is purified through a protein G column, followed by dialysis against PBS.
-
Immunogen
- Purified His-tagged VGFR3 protein(Fragment) was used to produced this monoclonal antibody.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- WB: 1:2000. IHC-P: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Expiry Date
- 6 months
-
-
-
: "miR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression." in: Cancer research, Vol. 74, Issue 21, pp. 6280-90, (2014) (PubMed).
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Alternative Name
- VGFR3
-
Background
- This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.
-
Molecular Weight
- 152757
-
Gene ID
- 2324
-
NCBI Accession
- NP_002011, NP_891555
-
UniProt
- P35916
-
Pathways
- RTK Signaling, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-